Professor
The University of Kentucky
Lexington, Kentucky, United States
Dr. Alice Thornton is a Professor of Medicine in the University of Kentucky Department of Internal Medicine and Chief of the UK Division of Infectious Diseases. Dr. Thornton completed her medical degree at Marshall University in Huntington, West Virginia.
She completed her residency at Wake Forest University School of Medicine in Internal Medicine. She then completed her fellowship training with the Division of Infectious Diseases at Indiana University Purdue University Indianapolis (IUPUI) where she studied the pathogenesis of chancroid. She was recruited to assist in the development of an Infectious Diseases Fellowship Program at the University of Kentucky in 1998.
Dr. Thornton has successfully acquired four HRSA funded grants – Ryan White Part B, C and D and the Local Performance Site grant of the Southeast AIDS Training and Education Center. She is the site PI for the Bluegrass Care Clinic NIH-funded REPRIEVE Study – Randomized Clinical Trial to Prevent Vascular Events in HIV.
Dr. Thornton is a clinical site visitor for Health Resources and Services Administration (HRSA), and has served as a grant reviewer for HRSA, National Institutes of Health (NIH), and the Centers for Disease Control and Prevention (CDC). Dr. Thornton is a member of the Ryan White Medical Providers Coalition Steering Committee, and has served on the HIVMA Board of Directors. Recently, she has devoted time establishing a one year HIV Fellowship and the program has graduated 1 physician and 2 physician assistants. Her ID Division has started a dedicated inpatient multidisiplinary endocarditis team and an innovative program, The WRAP, focusing on providing wrap around services for individuals who have substance use disorder and an infectious disease. During the COVID Pandemic, she and her colleague, Dr. Frank Romanelli, established a regular occuring KY COVID-19 Task Force that is a live webcast instructing Medical Providers on updated treatments and managment strategies for COVID.
Disclosure(s): No financial relationships to disclose
Friday, October 18, 2024
1:45 PM – 1:57 PM US PT